Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1982-9-17
|
pubmed:abstractText |
The antihypertensive effect of nifedipine during long-term therapy was investigated in 5 patients receiving nifedipine as the sole drug and in 10 patients who had nifedipine in combination with a beta-adrenoceptor blocking drug. Nifedipine monotherapy was problematic because of side-effects and development of resistance to therapy after a few months. In patients who received the combined therapy significant and stable blood pressure reductions were maintained during the whole observation period (12-33 months). However, the occurrence of peripheral oedema in 4 of the patients necessitated the addition of a thiazide diuretic. It is concluded that nifedipine is not a first choice drug for the long-term treatment of arterial hypertension. When given in addition to a beta-blocker it is well tolerated and powerful but fluid retention may occur and if not counteracted by a diuretic it will limit the antihypertensive potential of the drug.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0031-6970
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
101-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6124423-Adrenergic beta-Antagonists,
pubmed-meshheading:6124423-Adult,
pubmed-meshheading:6124423-Blood Pressure,
pubmed-meshheading:6124423-Drug Therapy, Combination,
pubmed-meshheading:6124423-Female,
pubmed-meshheading:6124423-Heart Rate,
pubmed-meshheading:6124423-Humans,
pubmed-meshheading:6124423-Hypertension,
pubmed-meshheading:6124423-Male,
pubmed-meshheading:6124423-Middle Aged,
pubmed-meshheading:6124423-Nifedipine,
pubmed-meshheading:6124423-Pyridines
|
pubmed:year |
1982
|
pubmed:articleTitle |
Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|